CD19 and systemic lupus erythematosus: found that serum BAFF levels were higher in SLE patients than in healthy controls and that BAFF levels were positively correlated with CD19+ B cell percentage and the MEX-SLEDAI disease activity score (the Mexican version of the lupus disease activity classification standard) in SLE patients.